{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:27:20Z","timestamp":1793366840421,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1177\/1933719116678686","type":"journal-article","created":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T20:40:19Z","timestamp":1479760819000},"page":"1235-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications"],"prefix":"10.1007","volume":"24","author":[{"given":"Mostafa A.","family":"Borahay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet R.","family":"Asoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymara","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan S.","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Al-Hendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,1]]},"reference":[{"issue":"8","key":"24091235_CR1","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0002-9378(15)30365-3","volume":"107","author":"DE Townsend","year":"1970","unstructured":"Townsend DE, Sparkes RS, Baluda MC, McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol. 1970;107(8):1168\u20131173.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"24091235_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-4608(91)90229-N","volume":"55","author":"N Pandis","year":"1991","unstructured":"Pandis N, Heim S, Bardi G, et al. Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 1991;55(1):11\u201318.","journal-title":"Cancer Genet Cytogenet"},{"issue":"14","key":"24091235_CR3","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344\u20131355.","journal-title":"N Engl J Med"},{"issue":"4","key":"24091235_CR4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","volume":"22","author":"S Okolo","year":"2008","unstructured":"Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):571\u2013588.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"24091235_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine M, Kaasinen E, Makinen N, et al. Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med. 2013;369(1):43\u201353.","journal-title":"N Engl J Med"},{"issue":"2","key":"24091235_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humupd\/dmt042","volume":"20","author":"R Tal","year":"2014","unstructured":"Tal R, Segars JH. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update. 2014;20(2):194\u2013216.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"24091235_CR7","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dep437","volume":"25","author":"KN Khan","year":"2010","unstructured":"Khan KN, Kitajima M, Hiraki K, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod. 2010;25(3):642\u2013653.","journal-title":"Hum Reprod"},{"key":"24091235_CR8","first-page":"CD000547","volume":"2","author":"A Lethaby","year":"2001","unstructured":"Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001(2):CD000547.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"24091235_CR9","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"2","key":"24091235_CR10","first-page":"307","volume":"13","author":"M Razandi","year":"1999","unstructured":"Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol. 1999;13(2):307\u2013319.","journal-title":"Mol Endocrinol"},{"issue":"15","key":"24091235_CR11","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s00018-009-0017-3","volume":"66","author":"S Ellmann","year":"2009","unstructured":"Ellmann S, Sticht H, Thiel F, Beckmann MW, Strick R, Strissel PL. Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci. 2009;66(15):2405\u20132426.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"24091235_CR12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2006.07.001","volume":"27","author":"P Ascenzi","year":"2006","unstructured":"Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med. 2006;27(4):299\u2013402.","journal-title":"Mol Aspects Med"},{"key":"24091235_CR13","doi-asserted-by":"crossref","first-page":"812540","DOI":"10.4061\/2011\/812540","volume":"2011","author":"R Kumar","year":"2011","unstructured":"Kumar R, Zakharov MN, Khan SH, et al. The dynamic structure of the estrogen receptor. J Amino Acids. 2011;2011:812540.","journal-title":"J Amino Acids"},{"key":"24091235_CR14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2119\/molmed.2014.00053","volume":"21","author":"MA Borahay","year":"2015","unstructured":"Borahay MA, Al-Hendy A, Kilic GS, Boehning D. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Mol Med. 2015;21:242\u2013256.","journal-title":"Mol Med"},{"issue":"1","key":"24091235_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/geno.1993.1320","volume":"17","author":"LP Menasce","year":"1993","unstructured":"Menasce LP, White GR, Harrison CJ, Boyle JM. Localization of the estrogen receptor locus (ESR) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics. 1993;17(1):263\u2013265.","journal-title":"Genomics"},{"issue":"12","key":"24091235_CR16","first-page":"4258","volume":"82","author":"E Enmark","year":"1997","unstructured":"Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab. 1997;82(12):4258\u20134265.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"24091235_CR17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1210\/endo.138.3.4979","volume":"138","author":"GG Kuiper","year":"1997","unstructured":"Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138(3):863\u2013870.","journal-title":"Endocrinology"},{"issue":"5","key":"24091235_CR18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/0929867003375010","volume":"7","author":"K Dechering","year":"2000","unstructured":"Dechering K, Boersma C, Mosselman S. Estrogen receptors alpha and beta: two receptors of a kind? Curr Med Chem. 2000;7(5):561\u2013576.","journal-title":"Curr Med Chem"},{"key":"24091235_CR19","volume-title":"Signal Transduction Research Trends","author":"NO Grachevsky","year":"2007","unstructured":"Grachevsky NO. Signal Transduction Research Trends. New York, NY: Nova Science Publishers; 2007."},{"issue":"5","key":"24091235_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mi.3.5.281","volume":"3","author":"J Matthews","year":"2003","unstructured":"Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3(5):281\u2013292.","journal-title":"Mol Interv"},{"issue":"9","key":"24091235_CR21","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1210\/me.2005-0525","volume":"20","author":"A Pedram","year":"2006","unstructured":"Pedram A, Razandi M, Levin ER. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol. 2006;20(9):1996\u20132009.","journal-title":"Mol Endocrinol"},{"issue":"pt21","key":"24091235_CR22","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1113\/jphysiol.2009.177097","volume":"587","author":"ER Levin","year":"2009","unstructured":"Levin ER. Membrane oestrogen receptor alpha signalling to cell functions. J Physiol. 2009;587(pt 21):5019\u20135023.","journal-title":"J Physiol"},{"issue":"5","key":"24091235_CR23","first-page":"938","volume":"16","author":"KL Chambliss","year":"2002","unstructured":"Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW. ERbeta has nongenomic action in caveolae. Mol Endocrinol. 2002;16(5):938\u2013946.","journal-title":"Mol Endocrinol"},{"issue":"1","key":"24091235_CR24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1091\/mbc.e11-07-0638","volume":"23","author":"A Pedram","year":"2012","unstructured":"Pedram A, Razandi M, Deschenes RJ, Levin ER. DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptors. Mol Biol Cell. 2012;23(1):188\u2013199.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"24091235_CR25","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2004-1064","volume":"146","author":"P Thomas","year":"2005","unstructured":"Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146(2):624\u2013632.","journal-title":"Endocrinology"},{"issue":"5715","key":"24091235_CR26","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","volume":"307","author":"CM Revankar","year":"2005","unstructured":"Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307(5715):1625\u20131630.","journal-title":"Science"},{"issue":"2","key":"24091235_CR27","first-page":"129","volume":"64","author":"K Soltysik","year":"2013","unstructured":"Soltysik K, Czekaj P. Membrane estrogen receptors\u2014is it an alternative way of estrogen action? J Physiol Pharmacol. 2013;64(2):129\u2013142.","journal-title":"J Physiol Pharmacol"},{"key":"24091235_CR28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.physiol.70.113006.100518","volume":"70","author":"ER Prossnitz","year":"2008","unstructured":"Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol. 2008;70:165\u2013190.","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"24091235_CR29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.tem.2009.06.009","volume":"20","author":"ER Levin","year":"2009","unstructured":"Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab. 2009;20(10):477\u2013482.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"24091235_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.11613\/BM.2014.035","volume":"24","author":"P Vrtacnik","year":"2014","unstructured":"Vrtacnik P, Ostanek B, Mencej-Bedrac S, Marc J. The many faces of estrogen signaling. Biochem Med (Zagreb). 2014;24(3):329\u2013342.","journal-title":"Biochem Med (Zagreb)"},{"key":"24091235_CR31","volume-title":"Molecular Cell Biology","author":"HF Lodish","year":"2008","unstructured":"Lodish HF. Molecular Cell Biology. 6th ed. New York, NY: W. H. Freeman; 2008.","edition":"6th ed"},{"issue":"5","key":"24091235_CR32","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1128\/MCB.19.5.3748","volume":"19","author":"R Knoblauch","year":"1999","unstructured":"Knoblauch R, Garabedian MJ. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol Cell Biol. 1999;19(5):3748\u20133759.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"24091235_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/153537020322800201","volume":"228","author":"WB Pratt","year":"2003","unstructured":"Pratt WB, Toft DO. Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery. Exp Biol Med (Maywood). 2003;228(2):111\u2013133.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"24091235_CR34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/jme.1.01541","volume":"33","author":"CM Klinge","year":"2004","unstructured":"Klinge CM, Jernigan SC, Mattingly KA, Risinger KE, Zhang J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol. 2004;33(2):387\u2013410.","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"24091235_CR35","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1210\/me.2003-0044","volume":"18","author":"R O\u2019Lone","year":"2004","unstructured":"O\u2019Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 2004;18(8):1859\u20131875.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"24091235_CR36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/me.2004-0486","volume":"19","author":"L Bjornstrom","year":"2005","unstructured":"Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 2005;19(4):833\u2013842.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"24091235_CR37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/embo-reports\/kve185","volume":"2","author":"JG Moggs","year":"2001","unstructured":"Moggs JG, Orphanides G. Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep. 2001;2(9):775\u2013781.","journal-title":"EMBO Rep"},{"issue":"42","key":"24091235_CR38","doi-asserted-by":"crossref","first-page":"35081","DOI":"10.1074\/jbc.C500353200","volume":"280","author":"P Monje","year":"2005","unstructured":"Monje P, Hernandez-Losa J, Lyons RJ, Castellone MD, Gutkind JS. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1. J Biol Chem. 2005;280(42):35081\u201335084.","journal-title":"J Biol Chem"},{"key":"24091235_CR39","volume-title":"The Biology of Cancer","author":"RA Weinberg","year":"2007","unstructured":"Weinberg RA. The Biology of Cancer. New York, NY: Garland Science; 2007."},{"issue":"5573","key":"24091235_CR40","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655\u20131657.","journal-title":"Science"},{"issue":"6","key":"24091235_CR41","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1349-7006.2009.01148.x","volume":"100","author":"YY He","year":"2009","unstructured":"He YY, Cai B, Yang YX, Liu XL, Wan XP. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK\/ERK mitogen-activated protein kinase pathway. Cancer Sci. 2009;100(6):1051\u20131061.","journal-title":"Cancer Sci"},{"issue":"7","key":"24091235_CR42","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1210\/en.2012-1061","volume":"153","author":"EJ Filardo","year":"2012","unstructured":"Filardo EJ, Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology. 2012;153(7):2953\u20132962.","journal-title":"Endocrinology"},{"issue":"6764","key":"24091235_CR43","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/47260","volume":"402","author":"N Prenzel","year":"1999","unstructured":"Prenzel N, Zwick E, Daub H, et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 1999;402(6764):884\u2013888.","journal-title":"Nature"},{"issue":"6","key":"24091235_CR44","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","volume":"101","author":"J Donnez","year":"2014","unstructured":"Donnez J, Vazquez F, Tomaszewski J, et al. Long-term treatment of uterine fibroids with ulipristal acetate. Fertil Steril. 2014;101(6):1565\u20131573.e1561-e1518.","journal-title":"Fertil Steril"},{"key":"24091235_CR45","first-page":"CD009505","volume":"10","author":"H Song","year":"2013","unstructured":"Song H, Lu D, Navaratnam K, Shi G. Aromatase inhibitors for uterine fibroids. Cochrane Database Syst Rev. 2013;(10):CD009505.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"24091235_CR46","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1210\/endo.141.10.7719","volume":"141","author":"H Sumitani","year":"2000","unstructured":"Sumitani H, Shozu M, Segawa T, et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine\/intracrine mechanism. Endocrinology. 2000;141(10):3852\u20133861.","journal-title":"Endocrinology"},{"issue":"2","key":"24091235_CR47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2004-828616","volume":"22","author":"JD Cook","year":"2004","unstructured":"Cook JD, Walker CL. Treatment strategies for uterine leiomyoma: the role of hormonal modulation. Semin Reprod Med. 2004;22(2):105\u2013111.","journal-title":"Semin Reprod Med"},{"issue":"3","key":"24091235_CR48","first-page":"736","volume":"78","author":"SE Bulun","year":"1994","unstructured":"Bulun SE, Simpson ER, Word RA. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture. J Clin Endocrinol Metab. 1994;78(3):736\u2013743.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1\u20135","key":"24091235_CR49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2005.04.012","volume":"95","author":"SE Bulun","year":"2005","unstructured":"Bulun SE, Imir G, Utsunomiya H, et al. Aromatase in endometriosis and uterine leiomyomata. J Steroid Biochem Mol Biol. 2005;95(1\u20135):57\u201362.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"24091235_CR50","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1210\/jc.2003-032085","volume":"89","author":"T Kasai","year":"2004","unstructured":"Kasai T, Shozu M, Murakami K, et al. Increased expression of type I 17beta-hydroxysteroid dehydrogenase enhances in situ production of estradiol in uterine leiomyoma. J Clin Endocrinol Metab. 2004;89(11):5661\u20135668.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"24091235_CR51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejogrb.2013.09.010","volume":"171","author":"N Duhan","year":"2013","unstructured":"Duhan N, Madaan S, Sen J. Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women. Eur J Obstet Gynecol Reprod Biol. 2013;171(2):329\u2013332.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"24091235_CR52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ogc.2005.12.001","volume":"33","author":"EE Marsh","year":"2006","unstructured":"Marsh EE, Bulun SE. Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am. 2006;33(1):59\u201367.","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"24091235_CR53","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","volume":"151","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 2010;151(6):2433\u20132442.","journal-title":"Endocrinology"},{"issue":"5","key":"24091235_CR54","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jc.2008-2327","volume":"94","author":"H Ishikawa","year":"2009","unstructured":"Ishikawa H, Reierstad S, Demura M, et al. High aromatase expression in uterine leiomyoma tissues of African-American women. J Clin Endocrinol Metab. 2009;94(5):1752\u20131756.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6pt1","key":"24091235_CR55","first-page":"E1112","volume":"276","author":"C Benassayag","year":"1999","unstructured":"Benassayag C, Leroy MJ, Rigourd V, et al. Estrogen receptors (ERalpha\/ERbeta) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma. Am J Physiol. 1999;276(6 pt 1):E1112\u2013E1118.","journal-title":"Am J Physiol"},{"issue":"1","key":"24091235_CR56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.fertnstert.2012.09.011","volume":"99","author":"R Tian","year":"2013","unstructured":"Tian R, Wang Z, Shi Z, et al. Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle. Fertil Steril. 2013;99(1):256\u2013263.","journal-title":"Fertil Steril"},{"issue":"6","key":"24091235_CR57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00428-008-0679-5","volume":"453","author":"TL Hermon","year":"2008","unstructured":"Hermon TL, Moore AB, Yu L, Kissling GE, Castora FJ, Dixon D. Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium. Virchows Arch. 2008;453(6):557\u2013569.","journal-title":"Virchows Arch"},{"issue":"6","key":"24091235_CR58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/molehr\/gah174","volume":"11","author":"CD Swartz","year":"2005","unstructured":"Swartz CD, Afshari CA, Yu L, Hall KE, Dixon D. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod. 2005;11(6):441\u2013450.","journal-title":"Mol Hum Reprod"},{"issue":"5","key":"24091235_CR59","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0002-9378(93)90293-R","volume":"169","author":"J Andersen","year":"1993","unstructured":"Andersen J, Grine E, Eng CL, et al. Expression of connexin-43 in human myometrium and leiomyoma. Am J Obstet Gynecol. 1993;169(5):1266\u20131276.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"24091235_CR60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/molehr\/6.1.55","volume":"6","author":"I Gustavsson","year":"2000","unstructured":"Gustavsson I, Englund K, Faxen M, Sjoblom P, Lindblom B, Blanck A. Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium. Mol Hum Reprod. 2000;6(1):55\u201359.","journal-title":"Mol Hum Reprod"},{"issue":"6","key":"24091235_CR61","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.fertnstert.2008.03.071","volume":"91","author":"IK Dimitrova","year":"2009","unstructured":"Dimitrova IK, Richer JK, Rudolph MC, et al. Gene expression profiling of multiple leiomyomata uteri and matched normal tissue from a single patient. Fertil Steril. 2009;91(6):2650\u20132663.","journal-title":"Fertil Steril"},{"issue":"3","key":"24091235_CR62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E","volume":"186","author":"A Barbarisi","year":"2001","unstructured":"Barbarisi A, Petillo O, Di Lieto A, et al. 17-Beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol. 2001;186(3):414\u2013424.","journal-title":"J Cell Physiol"},{"issue":"suppl2","key":"24091235_CR63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000055275","volume":"57","author":"H Matsuo","year":"1999","unstructured":"Matsuo H, Kurachi O, Shimomura Y, Samoto T, Maruo T. Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma. Oncology. 1999;57(suppl 2):49\u201358.","journal-title":"Oncology"},{"issue":"6","key":"24091235_CR64","first-page":"2192","volume":"83","author":"Y Shimomura","year":"1998","unstructured":"Shimomura Y, Matsuo H, Samoto T, Maruo T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab. 1998;83(6):2192\u20132198.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"24091235_CR65","first-page":"3915","volume":"87","author":"Z Gao","year":"2002","unstructured":"Gao Z, Matsuo H, Nakago S, Kurachi O, Maruo T. p53 Tumor suppressor protein content in human uterine leiomyomas and its down-regulation by 17 beta-estradiol. J Clin Endocrinol Metab. 2002;87(8):3915\u20133920.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"24091235_CR66","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/en.2008-0224","volume":"150","author":"EN Nierth-Simpson","year":"2009","unstructured":"Nierth-Simpson EN, Martin MM, Chiang TC, et al. Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation. Endocrinology. 2009;150(5):2436\u20132445.","journal-title":"Endocrinology"},{"issue":"5\u20136","key":"24091235_CR67","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.YU","volume":"14","author":"L Yu","year":"2008","unstructured":"Yu L, Saile K, Swartz CD, et al. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas. Mol Med. 2008;14(5\u20136):264\u2013275.","journal-title":"Mol Med"},{"issue":"8","key":"24091235_CR68","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.82.8.4141","volume":"82","author":"M Lessl","year":"1997","unstructured":"Lessl M, Klotzbuecher M, Schoen S, Reles A, Stockemann K, Fuhrmann U. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium. J Clin Endocrinol Metab. 1997;82(8):2596\u20132600.","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"24091235_CR69","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-08-4471","volume":"69","author":"JS Crabtree","year":"2009","unstructured":"Crabtree JS, Jelinsky SA, Harris HA, et al. Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway. Cancer Res. 2009;69(15):6171\u20136178.","journal-title":"Cancer Res"},{"issue":"8","key":"24091235_CR70","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.fertnstert.2009.03.100","volume":"93","author":"L Karra","year":"2010","unstructured":"Karra L, Shushan A, Ben-Meir A, et al. Changes related to phosphatidylinositol 3-kinase\/Akt signaling in leiomyomas: possible involvement of glycogen synthase kinase 3alpha and cyclin D2 in the pathophysiology. Fertil Steril. 2010;93(8):2646\u20132651.","journal-title":"Fertil Steril"},{"issue":"9","key":"24091235_CR71","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/molehr\/gan045","volume":"14","author":"H Asada","year":"2008","unstructured":"Asada H, Yamagata Y, Taketani T, et al. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation. Mol Hum Reprod. 2008;14(9):539\u2013545.","journal-title":"Mol Hum Reprod"},{"key":"24091235_CR72","doi-asserted-by":"crossref","first-page":"e66632","DOI":"10.1371\/journal.pone.0066632","volume":"8++6","author":"R Maekawa","year":"2013","unstructured":"Maekawa R, Sato S, Yamagata Y, et al. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas. PLoS One. 2013;8++(6):e66632.","journal-title":"PLoS One"},{"issue":"3","key":"24091235_CR73","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.fertnstert.2014.07.1238","volume":"102","author":"N Chabbert-Buffet","year":"2014","unstructured":"Chabbert-Buffet N, Esber N, Bouchard P. Fibroid growth and medical options for treatment. Fertil Steril. 2014;102(3):630\u2013639.","journal-title":"Fertil Steril"},{"issue":"2","key":"24091235_CR74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jsgi.2004.10.008","volume":"12","author":"A Di Lieto","year":"2005","unstructured":"Di Lieto A, De Falco M, Pollio F, et al. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas. J Soc Gynecol Investig. 2005;12(2):123\u2013128.","journal-title":"J Soc Gynecol Investig"},{"issue":"3","key":"24091235_CR75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1460447","volume":"146","author":"Y Wang","year":"2002","unstructured":"Wang Y, Matsuo H, Kurachi O, Maruo T. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells. Eur J Endocrinol. 2002;146(3):447\u2013456.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"24091235_CR76","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1071-5576(02)00184-3","volume":"10","author":"N Chegini","year":"2003","unstructured":"Chegini N, Kornberg L. Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma. J Soc Gynecol Investig. 2003;10(1):21\u201326.","journal-title":"J Soc Gynecol Investig"},{"issue":"2","key":"24091235_CR77","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bpobgyn.2007.07.010","volume":"22","author":"AE Lethaby","year":"2008","unstructured":"Lethaby AE, Vollenhoven BJ. An evidence-based approach to hormonal therapies for premenopausal women with fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(2):307\u2013331.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"24091235_CR78","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0015-0282(16)56214-1","volume":"60","author":"LM Kettel","year":"1993","unstructured":"Kettel LM, Murphy AA, Morales AJ, Rivier J, Vale W, Yen SS. Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Fertil Steril. 1993;60(4):642\u2013646.","journal-title":"Fertil Steril"},{"issue":"9","key":"24091235_CR79","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/humrep\/12.9.2028","volume":"12","author":"D Gonzalez-Barcena","year":"1997","unstructured":"Gonzalez-Barcena D, Alvarez RB, Ochoa EP, et al. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix. Hum Reprod. 1997;12(9):2028\u20132035.","journal-title":"Hum Reprod"},{"issue":"3","key":"24091235_CR80","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/jc.2007-2507","volume":"93","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa H, Fenkci V, Marsh EE, et al. CCAAT\/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma. J Clin Endocrinol Metab. 2008;93(3):981\u2013991.","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"24091235_CR81","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1021\/jm050723z","volume":"48","author":"CW Hummel","year":"2005","unstructured":"Hummel CW, Geiser AG, Bryant HU, et al. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats. J Med Chem. 2005;48(22):6772\u20136775.","journal-title":"J Med Chem"},{"issue":"1","key":"24091235_CR82","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.fertnstert.2008.09.064","volume":"93","author":"ME Parsanezhad","year":"2010","unstructured":"Parsanezhad ME, Azmoon M, Alborzi S, et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril. 2010;93(1):192\u2013198.","journal-title":"Fertil Steril"},{"issue":"3","key":"24091235_CR83","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.AOG.0000279151.20878.60","volume":"110","author":"FK Varelas","year":"2007","unstructured":"Varelas FK, Papanicolaou AN, Vavatsi-Christaki N, Makedos GA, Vlassis GD. The effect of anastrazole on symptomatic uterine leiomyomata. Obstet Gynecol. 2007;110(3):643\u2013649.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"24091235_CR84","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1472-6483(10)60246-5","volume":"17","author":"B Gurates","year":"2008","unstructured":"Gurates B, Parmaksiz C, Kilic G, Celik H, Kumru S, Simsek M. Reprod Biomed Online. 2008Oct;17(4):569\u201374.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"24091235_CR85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2004-823027","volume":"22","author":"M Shozu","year":"2004","unstructured":"Shozu M, Murakami K, Inoue M. Aromatase and leiomyoma of the uterus. Semin Reprod Med. 2004;22(1):51\u201360.","journal-title":"Semin Reprod Med"},{"issue":"1\u20132","key":"24091235_CR86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mrfmmm.2005.02.028","volume":"591","author":"JS Lewis","year":"2005","unstructured":"Lewis JS, Jordan VC. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutat Res. 2005;591(1\u20132):247\u2013263.","journal-title":"Mutat Res"},{"issue":"9880","key":"24091235_CR87","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","volume":"381","author":"J Cuzick","year":"2013","unstructured":"Cuzick J, Sestak I, Bonanni B, et al. Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet. 2013;381(9880):1827\u20131834.","journal-title":"Lancet"},{"issue":"7","key":"24091235_CR88","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","volume":"348","author":"BL Riggs","year":"2003","unstructured":"Riggs BL, Hartmann LC. Selective estrogen-receptor modulators\u2014mechanisms of action and application to clinical practice. N Engl J Med. 2003;348(7):618\u2013629.","journal-title":"N Engl J Med"},{"issue":"suppl3","key":"24091235_CR89","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.4103\/2141-9248.141955","volume":"4","author":"R Moroni","year":"2014","unstructured":"Moroni R, Vieira C, Ferriani R, Candido-Dos-Reis F, Brito L. Pharmacological treatment of uterine fibroids. Ann Med Health Sci Res. 2014;4(suppl 3):S185\u2013S192.","journal-title":"Ann Med Health Sci Res"},{"issue":"3","key":"24091235_CR90","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-007-9507-x","volume":"106","author":"R Mansel","year":"2007","unstructured":"Mansel R, Goyal A, Nestour EL, Masini-Eteve V, O\u2019Connell K; Afimoxifene Breast Pain Research Group. A phase II trial of afimoxifene (4-hydroxytamoxifen gel) for cyclical mastalgia in premenopausal women. Breast Cancer Res Treat. 2007;106(3):389\u2013397.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"24091235_CR91","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/cmdc.200700104","volume":"2","author":"CR Overk","year":"2007","unstructured":"Overk CR, Peng KW, Asghodom RT, et al. Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene. Chem Med Chem. 2007;2(10):1520\u20131526.","journal-title":"Chem Med Chem"},{"issue":"3","key":"24091235_CR92","first-page":"299","volume":"2","author":"DM Biskobing","year":"2007","unstructured":"Biskobing DM. Update on bazedoxifene: a novel selective estrogen receptor modulator. Clin Interv Aging. 2007;2(3):299\u2013303.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"24091235_CR93","first-page":"9","volume":"32","author":"N Ohara","year":"2005","unstructured":"Ohara N. Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma. Clin Exp Obstet Gynecol. 2005;32(1):9\u201311.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"2","key":"24091235_CR94","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0301-2115(00)00468-1","volume":"96","author":"O Sadan","year":"2001","unstructured":"Sadan O, Ginath S, Sofer D, et al. The role of tamoxifen in the treatment of symptomatic uterine leiomyomata\u2014a pilot study. Eur J Obstet Gynecol Reprod Biol. 2001;96(2):183\u2013186.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"24091235_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)43749-0","volume":"31","author":"LC Huppert","year":"1979","unstructured":"Huppert LC. Induction of ovulation with clomiphene citrate. Fertil Steril. 1979;31(1):1\u20138.","journal-title":"Fertil Steril"},{"issue":"12","key":"24091235_CR96","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/humrep\/17.12.3213","volume":"17","author":"S Palomba","year":"2002","unstructured":"Palomba S, Russo T, Orio F Jr., et al. Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Hum Reprod. 2002;17(12):3213\u20133219.","journal-title":"Hum Reprod"},{"issue":"6","key":"24091235_CR97","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.fertnstert.2004.03.009","volume":"81","author":"S Palomba","year":"2004","unstructured":"Palomba S, Zullo F, Orio F Jr., Lombardi G. Does raloxifene inhibit the growth of uterine fibroids? Fertil Steril. 2004;81(6):1719\u20131720; author reply 1720-1711.","journal-title":"Fertil Steril"},{"issue":"5","key":"24091235_CR98","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/del515","volume":"22","author":"J Liu","year":"2007","unstructured":"Liu J, Matsuo H, Xu Q, Chen W, Wang J, Maruo T. Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro. Hum Reprod. 2007;22(5):1253\u20131259.","journal-title":"Hum Reprod"},{"issue":"1","key":"24091235_CR99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(01)01849-0","volume":"76","author":"S Palomba","year":"2001","unstructured":"Palomba S, Sammartino A, Di Carlo C, Affinito P, Zullo F, Nappi C. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women. Fertil Steril. 2001;76(1):38\u201343.","journal-title":"Fertil Steril"},{"issue":"1","key":"24091235_CR100","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.fertnstert.2004.12.058","volume":"84","author":"S Palomba","year":"2005","unstructured":"Palomba S, Orio F Jr., Russo T, et al. Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women. Fertil Steril. 2005;84(1):154\u2013161.","journal-title":"Fertil Steril"},{"key":"24091235_CR101","first-page":"CD005287","volume":"10","author":"L Deng","year":"2012","unstructured":"Deng L, Wu T, Chen XY, Xie L, Yang J. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. Cochrane Database Syst Rev. 2012;10:CD005287.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"24091235_CR102","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/humupd\/dml015","volume":"12","author":"A Al-Hendy","year":"2006","unstructured":"Al-Hendy A, Salama S. Gene therapy and uterine leiomyoma: a review. Hum Reprod Update. 2006;12(4):385\u2013400.","journal-title":"Hum Reprod Update"},{"issue":"5","key":"24091235_CR103","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ajog.2004.04.022","volume":"191","author":"A Al-Hendy","year":"2004","unstructured":"Al-Hendy A, Lee EJ, Wang HQ, Copland JA. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol. 2004;191(5):1621\u20131631.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"24091235_CR104","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jsgi.2006.09.003","volume":"13","author":"SA Salama","year":"2006","unstructured":"Salama SA, Nasr AB, Dubey RK, Al-Hendy A. Estrogen metabolite 2-methoxyestradiol induces apoptosis and inhibits cell proliferation and collagen production in rat and human leiomyoma cells: a potential medicinal treatment for uterine fibroids. J Soc Gynecol Investig. 2006;13(8):542\u2013550.","journal-title":"J Soc Gynecol Investig"},{"issue":"10","key":"24091235_CR105","doi-asserted-by":"crossref","first-page":"e7356","DOI":"10.1371\/journal.pone.0007356","volume":"4","author":"SA Salama","year":"2009","unstructured":"Salama SA, Kamel MW, Botting S, et al. Catechol-o-methyltransferase expression and 2-methoxyestradiol affect microtubule dynamics and modify steroid receptor signaling in leiomyoma cells. PLoS One. 2009;4(10):e7356.","journal-title":"PLoS One"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116678686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719116678686","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719116678686\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719116678686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719116678686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T21:59:06Z","timestamp":1656799146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719116678686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["24091235"],"URL":"https:\/\/doi.org\/10.1177\/1933719116678686","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"1 September 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}